Multiple gastric neuroendocrine tumors in a patient with parietal cell dysfunction and adenosine triphosphatase H

Carcinoid H+/K+ ATPase Parietal cell protrusion Rindi’s classification

Journal

Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246

Informations de publication

Date de publication:
18 Apr 2024
Historique:
received: 05 01 2024
accepted: 01 04 2024
medline: 18 4 2024
pubmed: 18 4 2024
entrez: 18 4 2024
Statut: aheadofprint

Résumé

A 47-year-old woman presented with multiple gastric tumors, each up to 10 mm in diameter, in the gastric body and fundus without mucosal atrophy. White spots and numerous transparent, light-brownish, small, and rounded spots were observed in the background gastric mucosa. Biopsy specimens obtained from the tumors revealed gastric neuroendocrine tumors. The patient exhibited hypergastrinemia and achlorhydria and tested negative for serum parietal cell antibody, intrinsic factor antibody, and Helicobacter pylori infection. Moreover, no additional lesions were detected on imaging. These findings were inconsistent with Rindi's classification. The tumor was resected via endoscopic submucosal resection. Histopathological examination revealed gastric neuroendocrine tumors G2 infiltrating the submucosa with no atrophy of the gastric mucosa, dilated fundic glands, parietal cell protrusions, and hyperplasia of enterochromaffin-like cells. Immunohistochemically, the parietal cells were negative for both α- and β-subunits of H

Identifiants

pubmed: 38635098
doi: 10.1007/s12328-024-01969-0
pii: 10.1007/s12328-024-01969-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. Japanese Society of Gastroenterology.

Références

Rindi G, Luinetti O, Cornaggia M, et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993;104:994–1006.
doi: 10.1016/0016-5085(93)90266-F pubmed: 7681798
Ooi A, Ota M, Katsuda S, et al. An unusual case of multiple gastric carcinoids associated with diffuse endocrine cell hyperplasia and parietal cell hypertrophy. Endocr Pathol. 1995;6:229–37.
doi: 10.1007/BF02739887 pubmed: 12114744
Abraham SC, Carney JA, Ooi A, et al. Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids: a new disorder. Am J Surg Pathol. 2005;29:969–75.
doi: 10.1097/01.pas.0000163363.86099.9f pubmed: 15958864
Nakata K, Aishima S, Ichimiya H, et al. Unusual multiple gastric carcinoids with hypergastrinemia: report of a case. Surg Today. 2010;40:267–71.
doi: 10.1007/s00595-009-4032-7 pubmed: 20180083
Ishioka M, Hirasawa T, Kawachi H, et al. Enterochromaffin-like cell neuroendocrine tumor associated with parietal cell dysfunction. Gastrointest Endosc. 2019;90:841–5.
doi: 10.1016/j.gie.2019.06.029 pubmed: 31276673
Ihara Y, Umeno J, Hori Y. Type IV gastric carcinoids in the stomach caused by ATP4A gene mutations. Clin Gastroenterol Hepatol. 2020;18:A22.
doi: 10.1016/j.cgh.2019.07.063 pubmed: 31401365
Hirai R, Haruma K, Okada H, et al. A case of enterochromaffin-like cell neuroendocrine tumor associated with parietal cell dysfunction which was successfully treated with somatostatin analogue. Clin J Gastroenterol. 2022;15:363–7.
doi: 10.1007/s12328-021-01581-6 pubmed: 34982362
Abe Y, Hatta W, Asonuma S, et al. Parietal cell dysfunction: a rare cause of gastric neuroendocrine neoplasm with achlorhydria and extreme hypergastrinemia. Intern Med. 2022;61:2441–8.
doi: 10.2169/internalmedicine.8253-21 pubmed: 35110476 pmcid: 9449610
Shiroma S, Higuchi K, Ota H, et al. A rare case of an enterochromaffin-like neuroendocrine tumor associated with parietal cell dysfunction treated using endoscopic submucosal dissection. Clin J Gastroenterol. 2022;15:1041–7.
doi: 10.1007/s12328-022-01704-7 pubmed: 36125703
Namikawa K, Kamada T, Fujisaki J, et al. Clinical characteristics and long-term prognosis of type 1 gastric neuroendocrine tumors in a large Japanese national cohort. Dig Endosc. 2023;35:757–66.
doi: 10.1111/den.14529 pubmed: 36721901
Rugge M, Bricca L, Guzzinati S, et al. Autoimmune gastritis: long-term natural history in naive Helicobacter pylori-negative patients. Gut. 2023;72:30–8.
doi: 10.1136/gutjnl-2022-327827 pubmed: 35772926
Miceli E, Lenti MV, Gentile A, et al. Long-term natural history of autoimmune gastritis: results from a prospective, monocentric series. Am J Gastroenterol. 2023. https://doi.org/10.14309/ajg.0000000000002619
Terao S, Suzuki S, Yaita H, et al. Multicenter study of autoimmune gastritis in Japan: Clinical and endoscopic characteristics. Dig Endosc. 2020;32:364–72.
doi: 10.1111/den.13500 pubmed: 31368581
Singh V, Mani I, Chaudhary DK. ATP4A gene regulatory network for fine-tuning of proton pump and ion channels. Syst Synth Biol. 2013;7:23–32.
doi: 10.1007/s11693-012-9103-1 pubmed: 24432139 pmcid: 3641282
Du Z, Deng S, Wu Z, et al. Genome-wide analysis of haloacid dehalogenase genes reveals their function in phosphate starvation responses in rice. PLoS ONE. 2021;16:1–17.
doi: 10.1371/journal.pone.0245600
Calvete O, Reyes J, Zuñiga S, et al. Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastricneuroendocrine tumour. Hum Mol Genet. 2015;24:2914–22.
doi: 10.1093/hmg/ddv054 pubmed: 25678551
Spicer Z, Miller ML, Andringa A, et al. Stomachs of mice lacking the gastric H, K-ATPase α-subunit have achlorhydria, abnormal parietal cells, and ciliated metaplasia. J Biol Chem. 2000;275:21555–65.
doi: 10.1074/jbc.M001558200 pubmed: 10764766
Scarff KL, Judd LM, Toh B, et al. Gastric H+, K+-adenosine triphosphatase β subunit is required for normal function, development, and membrane structure of mouse parietal cells. Gastroenterology. 1999;117:605–18.
doi: 10.1016/S0016-5085(99)70453-1 pubmed: 10464136
Rubio CA, Miller ML. Fundic gland cysts in Atp4a−/− mice mimic fundic gland polyps in humans. In Vivo (Brooklyn). 2009;23:979–81.
Calvete O, Varro A, Pritchard DM, et al. A knockin mouse model for human ATP4aR703C mutation identified in familial gastric neuroendocrine tumors recapitulates the premalignant condition of the human disease and suggests new therapeutic strategies. Dis Model Mech. 2016;9:975–84.
pubmed: 27491072 pmcid: 5047686
Narimatsu H. Constructing a contemporary gene–environmental cohort: study design of the Yamagata molecular epidemiological cohort study. J Hum Genet. 2013;58:54–6.
doi: 10.1038/jhg.2012.128 pubmed: 23171998

Auteurs

Yu Sasaki (Y)

Faculty of Medicine, Department of Gastroenterology, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan. y-sasaki@med.id.yamagata-u.ac.jp.

Yasuhiko Abe (Y)

Division of Endoscopy, Yamagata University Hospital, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Ken Haruma (K)

Department of General Internal Medicine 2, Kawasaki Medical School General Medical Center, 2‑6‑1, Nakasange, Kitaku, Okayama, 700‑8505, Japan.

Hidenori Sato (H)

Division of Multi-Omics Research, Yamagata University Well-Being Institute, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Makoto Yagi (M)

Division of Endoscopy, Yamagata University Hospital, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Naoko Mizumoto (N)

Faculty of Medicine, Department of Gastroenterology, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Yusuke Onozato (Y)

Faculty of Medicine, Department of Gastroenterology, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Minami Ito (M)

Faculty of Medicine, Department of Gastroenterology, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Takahiro Watabe (T)

Faculty of Medicine, Department of Gastroenterology, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Yoshiyuki Ueno (Y)

Faculty of Medicine, Department of Gastroenterology, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Classifications MeSH